Sonova (OTCMKTS:SONVY - Get Free Report) was downgraded by equities researchers at Barclays from a "hold" rating to a "strong sell" rating in a report issued on Friday,Zacks.com reports.
Several other analysts have also commented on the stock. BNP Paribas lowered shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research report on Wednesday, June 11th. Kepler Capital Markets raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. HSBC lowered shares of Sonova from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Finally, Hsbc Global Res lowered shares of Sonova from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Four analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to data from MarketBeat, Sonova presently has a consensus rating of "Hold".
Read Our Latest Research Report on SONVY
Sonova Stock Down 2.0%
SONVY opened at $59.16 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.27 and a quick ratio of 0.96. Sonova has a fifty-two week low of $52.83 and a fifty-two week high of $77.56. The company's 50-day moving average is $61.89 and its 200 day moving average is $63.43.
About Sonova
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.